首页> 外文OA文献 >Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204

【2h】

Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204

机译：II期术前辐射与同时杂志，Oxaliplatin和Bevacizumab，其次是手术和术后5-FU，Leucovorin，Oxaliplatin（Folfox）和北伐单抗在局部晚肠癌患者中的术语：ECOG 3204

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
J.C. Landry; P. Catalano; S.J. Cohen; C. Staley; E. Sigurdson; Y. Feng; A.B. Benson;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204 [J] . Landry Jerome C., Feng Yang, Prabhu Roshan S., The oncologist . 2015,第6期

机译：局部晚期直肠癌患者术前放开卡培他滨，奥沙利铂和贝伐单抗并发手术及术后5-氟尿嘧啶，白叶素，奥沙利铂（FOLFOX）和贝伐单抗的术前放疗的二期试验：5年临床结果ECOG-ACRIN癌症研究E3204组
2. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204 [J] . Jerome C. Landry, Yang Feng, Roshan S. Prabhu, The oncologist . 2015,第6期

机译：局部晚期直肠癌患者术前并发卡培他滨，奥沙利铂和贝伐单抗联合手术及术后5-氟尿嘧啶，白叶素，奥沙利铂（FOLFOX）和贝伐单抗的术前放疗的二期试验：5年临床结果E3204组
3. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204 [J] . LandryJ.C., FengY., CohenS.J., Cancer: A Journal of the American Cancer Society . 2013,第8期

机译：局部晚期直肠癌患者术前放疗并发卡培他滨，奥沙利铂和贝伐单抗，然后进行手术以及术后5-氟尿嘧啶，亚叶酸，奥沙利铂（FOLFOX）和贝伐单抗的术前放疗：ECOG 3204
4. Functional outcome after concurrent chemoradiation in patients with locally advanced laryngeal or hypopharyngeal cancer [C] . Furukawa Madoka K., Kubota A., Yagi H., World Congress for Bronchology and Interventional Pulmonology . 2013

机译：在局部晚期喉部或白阴癌患者的同时趋化后的功能结果
5. Phase II Study of Preoperative Radiation with Concurrent Capecitabine Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU Leucovorin Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204 [O] . Jerome C. Landry, Yang Feng, Steven J. Cohen, -1

机译：II期术前辐射与同时杂志Oxaliplatin和Bevacizumab其次是手术和术后5-FULeucovorinOxaliplatin（Folfox）和北伐单抗在局部晚肠癌患者中的术语：ECOG 3204
6. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204) [O] . A. Bapsi Chakravarthy, Fengmin Zhao, Neal J. Meropol, 2019

机译：术后Oxaliplatin，5-氟尿嘧啶和白杨蛋白的跨组随机化第三阶段研究术前II或III型直肠癌患者的奥沙利铂，5-氟尿嘧啶，白草素和Bevacizumab接受术前化学校长：ECOG-acrin研究组的试验（E5204 ）

Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204

著录项

相似文献

相关主题

期刊订阅